These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30805315)

  • 1. A cautionary note on the selectivity of oncolytic poxviruses.
    Tang B; Guo ZS; Bartlett DL; Liu J; McFadden G; Shisler JL; Roy EJ
    Oncolytic Virother; 2019; 8():3-8. PubMed ID: 30805315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.
    Tang B; Guo ZS; Bartlett DL; Yan DZ; Schane CP; Thomas DL; Liu J; McFadden G; Shisler JL; Roy EJ
    Clin Cancer Res; 2020 May; 26(9):2216-2230. PubMed ID: 32019860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity.
    Tosic V; Thomas DL; Kranz DM; Liu J; McFadden G; Shisler JL; MacNeill AL; Roy EJ
    PLoS One; 2014; 9(10):e109801. PubMed ID: 25329832
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Giehl E; Kosaka H; Liu Z; Feist M; Kammula US; Lotze MT; Ma C; Guo ZS; Bartlett DL
    Front Immunol; 2021; 12():610042. PubMed ID: 33679747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.
    Zeh HJ; Downs-Canner S; McCart JA; Guo ZS; Rao UN; Ramalingam L; Thorne SH; Jones HL; Kalinski P; Wieckowski E; O'Malley ME; Daneshmand M; Hu K; Bell JC; Hwang TH; Moon A; Breitbach CJ; Kirn DH; Bartlett DL
    Mol Ther; 2015 Jan; 23(1):202-14. PubMed ID: 25292189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.
    Lun X; Ruan Y; Jayanthan A; Liu DJ; Singh A; Trippett T; Bell J; Forsyth P; Johnston RN; Narendran A
    Mol Oncol; 2013 Oct; 7(5):944-54. PubMed ID: 23816608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
    Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
    J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro.
    Jiang B; Lun X; Hao X; Wang Y; Yin X; Huang D; He W; Wang Z
    Biomed Pharmacother; 2017 Nov; 95():1201-1208. PubMed ID: 28931212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Poxviruses.
    Chan WM; McFadden G
    Annu Rev Virol; 2014 Sep; 1(1):119-141. PubMed ID: 25839047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.
    Chalikonda S; Kivlen MH; O'Malley ME; Eric Dong XD; McCart JA; Gorry MC; Yin XY; Brown CK; Zeh HJ; Guo ZS; Bartlett DL
    Cancer Gene Ther; 2008 Feb; 15(2):115-25. PubMed ID: 18084242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.
    Guse K; Sloniecka M; Diaconu I; Ottolino-Perry K; Tang N; Ng C; Le Boeuf F; Bell JC; McCart JA; Ristimäki A; Pesonen S; Cerullo V; Hemminki A
    J Virol; 2010 Jan; 84(2):856-66. PubMed ID: 19906926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
    Pisklakova A; McKenzie B; Zemp F; Lun X; Kenchappa RS; Etame AB; Rahman MM; Reilly K; Pilon-Thomas S; McFadden G; Kurz E; Forsyth PA
    Neuro Oncol; 2016 Aug; 18(8):1088-1098. PubMed ID: 26962017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
    Barrett JW; Alston LR; Wang F; Stanford MM; Gilbert PA; Gao X; Jimenez J; Villeneuve D; Forsyth P; McFadden G
    J Neurovirol; 2007 Dec; 13(6):549-60. PubMed ID: 18097886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses.
    Mundi N; Um S; Yoo J; Rizzo G; Black M; Pinto N; Palma DA; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
    Virus Res; 2014 Sep; 190():53-9. PubMed ID: 25038405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular injection of myxoma virus results in transient expression of viral protein in mouse brain ependymal and subventricular cells.
    France MR; Thomas DL; Liu J; McFadden G; MacNeill AL; Roy EJ
    J Gen Virol; 2011 Jan; 92(Pt 1):195-9. PubMed ID: 20861319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.
    Stanford MM; McFadden G
    Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.
    Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN
    J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy with Myxoma Virus.
    Rahman MM; McFadden G
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.